| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | Mar 26, 2024 | Option Exercise | $22.72 | 11,197 | 254,396 | 190,476 | Mar 27, 2024, 04:30 PM | |
| NAMS | NewAmsterdam Pharma Co N.V. | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | Mar 26, 2024 | Sale | $21.50 | 190,476 | 4,095,234 | 0 | Mar 27, 2024, 04:30 PM |
Menu